1. Home
  2. CBRL vs KURA Comparison

CBRL vs KURA Comparison

Compare CBRL & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cracker Barrel Old Country Store Inc

CBRL

Cracker Barrel Old Country Store Inc

HOLD

Current Price

$27.88

Market Cap

694.2M

ML Signal

HOLD

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

HOLD

Current Price

$8.63

Market Cap

744.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBRL
KURA
Founded
1969
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
694.2M
744.0M
IPO Year
1998
2015

Fundamental Metrics

Financial Performance
Metric
CBRL
KURA
Price
$27.88
$8.63
Analyst Decision
Hold
Buy
Analyst Count
8
10
Target Price
$37.75
$26.63
AVG Volume (30 Days)
1.1M
1.6M
Earning Date
06-04-2026
01-01-0001
Dividend Yield
3.63%
N/A
EPS Growth
12.57
N/A
EPS
N/A
N/A
Revenue
$3,030,445,000.00
$67,482,000.00
Revenue This Year
N/A
$124.03
Revenue Next Year
$3.62
$28.63
P/E Ratio
N/A
N/A
Revenue Growth
3.56
25.24
52 Week Low
$24.85
$5.41
52 Week High
$68.09
$12.49

Technical Indicators

Market Signals
Indicator
CBRL
KURA
Relative Strength Index (RSI) 36.85 48.10
Support Level $25.24 $7.99
Resistance Level $29.73 $10.50
Average True Range (ATR) 1.57 0.41
MACD -0.51 0.05
Stochastic Oscillator 9.07 45.83

Price Performance

Historical Comparison
CBRL
KURA

About CBRL Cracker Barrel Old Country Store Inc

Cracker Barrel Old Country Store Inc operates hundreds of full-service restaurants throughout the United States. The Cracker Barrel stores consists of a restaurant with a gift shop. The restaurants serve breakfast, lunch and dinner. The gift shop offers a variety of decorative and functional items specializing in rocking chairs, holiday gifts, toys, apparel and foods.

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

Share on Social Networks: